Navigation Links
QIO Support Accelerates Hospital Improvement in Heart Care, Researchers Find
Date:6/3/2009

WASHINGTON, June 3 /PRNewswire-USNewswire/ -- The following is being issued by The American Health Quality Association (AHQA):

Technical support provided by federally funded organizations operating in every state has had a substantial role in upgrading hospital care in the U.S. during a period when hospital performance improved faster than outpatient care, according to a new federal report.

The annual National Healthcare Quality Report, just released by the U.S. Agency for Healthcare Research and Quality (AHRQ), finds that essential treatment for Medicare patients with heart failure was provided 73.4% of the time in 2002, with that percentage jumping to 77.7% in 2004. From 2005 to 2006, for all payors, performance on two key heart failure measures improved from 88.4% to 90.7% for one measure, and from 82.9% to 85.2% for the other.

"The work of Quality Improvement Organizations (QIOs) contributed substantially to the rapid improvement in the Hospital Quality Alliance measures they track," say the authors of the AHRQ report. The Hospital Quality Alliance is a national multi-stakeholder organization that promotes the use of a common set of performance measures in order to track performance at the state and provider level. The AHRQ report says the most recent data indicate that hospitals are improving on key performance measures at a rate of almost 3% a year, while care in ambulatory settings is improving by only a little more than 1% a year.

"We are very pleased that the national quality-of-care 'snapshot' released by AHRQ recognizes the important work the QIOs are doing to accelerate improvement on quality performance indicators important to our nation's seniors," said David Schulke of The American Health Quality Association, which represents QIOs in Washington DC. "While there is much more that QIOs can do to help hospitals upgrade the quality of care purchased by Medicare, this AHRQ report demonstrates that QIOs are already supporting tangible gains in important areas like management of heart failure and heart attack."

AHRQ cites the current three-year workplan that QIOs are now embarked on as holding significant promise for making additional improvements in Medicare quality. QIO contracts with the Centers for Medicare & Medicaid (CMS) run through 2011.

"New activities include work on projects that span the entire spectrum of the health community," say the authors of the report. This includes "intensive support of providers most in need of QIO assistance, and development of a more robust monitoring framework that will track the impact QIOs are having on the quality of care provided to Medicare beneficiaries."

The National Healthcare Quality Report 2008 is available at http://www.ahrq.gov/qual/qrdr08.htm.


'/>"/>
SOURCE The American Health Quality Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HIV therapy in pregnancy-data support WHO recommendations
2. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
3. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
4. Family-based treatment more effective than supportive psychotherapy in treating bulimia
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
7. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
8. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
9. Hundreds of MADD Supporters Meet in St. Louis on Sept. 6-8
10. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
11. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: